GlaxoSmithKline
GSK
$44.88
Share price
-0.98%
Change (1 day)
23.06%
Change (1 year)
Categories
GlaxoSmithKline (GSK) Fails to deliver data
Key failure to deliver metrics for GlaxoSmithKline:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $2.46 M
- Last 3 months FTD volume: $18.31 M
- Last year FTD volume: $24.09 M
Failures to deliver for GlaxoSmithKline (GSK) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022
Volume in USD (price x number of shares), data since 2022GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $18.87 M | -36.88% |
| 2023 | $29.9 M | -43.98% |
| 2022 | $53.37 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novartis NVS | $18.64 M | $83.53 M | 🇨🇭 Switzerland |
 Pfizer PFE | $10.32 M | $0.31 B | 🇺🇸 USA |
 Sanofi SNY | $21.22 M | $52.23 M | 🇫🇷 France |
 Merck MRK | $6.57 M | $0.15 B | 🇺🇸 USA |
 AstraZeneca AZN | $88.62 M | $0.16 B | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $5.61 M | $30.31 M | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.18 M | $2.21 M | 🇺🇸 USA |